Sanguine Media Limited narrowed its net loss to ₹0.41 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹15.98 lakh in the previous year, as total expenses reduced significantly. The company's board approved the standalone audited financial results for the quarter and year ended March 31, 2026, at a meeting held on June 09, 2026.

Revenue from operations for FY26 stood at ₹9.53 lakh, a decrease from ₹12.25 lakh in FY25. For the quarter ended March 31, 2026, the company reported a net loss of ₹0.70 lakh on revenue of ₹1.41 lakh. Total expenses for the full year reduced to ₹9.95 lakh from ₹28.23 lakh in the prior year, primarily due to a decrease in other expenses and changes in inventories.

The financial results were reviewed by the audit committee and audited by K. S. Subrahmanyam & Co., Chartered Accountants, the statutory auditors of the company. The auditors issued an audit report with an unmodified opinion on the standalone financial results, confirming compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

The company reported no outstanding defaults on loans or debt securities as of the date of the filing. Total financial indebtedness, including short-term and long-term debt, was nil. No related party transactions were reported during the financial year ended March 31, 2026.

Balance Sheet Highlights

The company's total assets stood at ₹12,309.10 lakh as of March 31, 2026, slightly down from ₹12,309.26 lakh in the previous year. Non-current assets, primarily comprising investments and loans, totaled ₹6,299.20 lakh. Current assets were reported at ₹6,009.90 lakh, which included inventories of ₹1,260.15 lakh and trade receivables of ₹1,530.43 lakh.

Equity share capital remained constant at ₹11,410.00 lakh. Total equity amounted to ₹12,134.42 lakh. Current liabilities, which include borrowings of ₹133.50 lakh and trade payables of ₹41.18 lakh, aggregated to ₹174.68 lakh.

Sanguine Media Limited has adjourned its board meeting to June 9, 2026, to conclude the approval of the audited financial results for the quarter and financial year ended March 31, 2026. The board initially convened on May 29, 2026, and reconvened on May 30, 2026, but could not complete the agenda due to pending discussions on the financial statements. The final meeting is scheduled to take place at the company's registered office in Chennai.

The board deliberated extensively on the audited financial results and other related financial statements during the sessions on May 29 and May 30. The discussions on May 29 continued until 8:30 P.M., and the meeting resumed on May 30 at 11:00 A.M., lasting until 6:35 P.M. The adjournment was necessitated by the requirement for further consideration of the financial statements and related matters.

Key Meeting Details

The outcome of the adjourned board meeting will be submitted to the stock exchange immediately upon conclusion. The approval of the financial results will provide insights into the company's performance for the final quarter of FY26 and the annual financial outcome. The intimation was submitted to BSE Limited under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.